Effect of Circadian Rhythm and Physical Exercise in Overweight Type 1 Diabetes Patients
Elucidating the Interplay Between Circadian Rhythm and Physical Exercise on Metabolism in Patients With Type 1 Diabetes and Overweight
1 other identifier
interventional
50
1 country
1
Brief Summary
Cardiometabolic risk in patients with abdominal obesity and type 1 diabetes can be moderated by life style modifications. There is an intimate link between gene regulation and circadian rhythm in mediating response to exercise in a variety of insulin sensitive organs. The aim of this project is to evaluate, by intervention, the interplay of circadian rhythm and high intensity interval training (HIIT) on glucose control and skeletal muscle metabolism in patients with overweight with or without type 1 diabetes (T1D).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 18, 2022
CompletedFirst Posted
Study publicly available on registry
March 14, 2022
CompletedStudy Start
First participant enrolled
May 18, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2026
ExpectedOctober 15, 2024
October 1, 2024
3.5 years
February 18, 2022
October 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time in Glucose target range (4-10 mmol/L) for tissue glucose from CGM.
Time in target glucose range (expressed as % of total time) measured by continuous subcutaneous glucose sensors following morning or afternoon HIIT respectively. Measurements are uploaded from the CGM device and analyzed.
48 hours
Secondary Outcomes (2)
Tissue specific effects of HIIT in type 1 diabetes vs healthy subjects
2 hours; muscle and blood samples are collected directly before and after HIIT, respectively.
Time below Glucose target range (< 4 mmol/L) for tissue glucose from CGM.
48 hours
Study Arms (2)
Type 1 diabetes with overweight
ACTIVE COMPARATORHigh intensity interval training (HIIT), a single bout, randomly performed either in the morning or in the afternoon in a cross-over design.
Overweight but otherwise healthy control subjects
ACTIVE COMPARATORHigh intensity interval training (HIIT), a single bout, randomly performed either in the morning or in the afternoon in a cross-over design.
Interventions
HIIT performed either in the morning or in the afternoon
Eligibility Criteria
You may qualify if:
- BMI 25-30
- type 1 diabetes or healthy subjects
You may not qualify if:
- nicotine usage,
- cardiovascular disease (CVD),
- blood pressure \>160/95,
- pregnancy,
- treatment with other pharmaceutical drugs than insulin, stable dose of thyroid hormone, statins, and antihypertensive drugs (excluding beta blockers).
- diabetes duration less than 6 months,
- proliferative or severe non-proliferative retinopathy,
- chronic kidney disease with glomerular filtration rate (GFR) \<60 ml/min,
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ersta sjukhus
Stockholm, 11691, Sweden
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ingrid Dahlman, Professor
Karolinska Institutet
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 18, 2022
First Posted
March 14, 2022
Study Start
May 18, 2022
Primary Completion
October 31, 2025
Study Completion (Estimated)
October 31, 2026
Last Updated
October 15, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share